<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Renaissance Capital IPO Research - Seeking Alpha</title>
    <description>© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (http://seekingalpha.com/page/terms-of-use). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.</description>
    <author>
      <name>SeekingAlpha.com</name>
    </author>
    <link>http://seekingalpha.com/author/renaissance-capital-ipo-research</link>
    <item>
      <title>6 U.S. IPOs Planned For The Week Of May 20</title>
      <link>http://seekingalpha.com/article/1448151-6-u-s-ipos-planned-for-the-week-of-may-20?source=feed</link>
      <guid isPermaLink="false">1448151</guid>
      <content>
        <![CDATA[<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p> <p><b>Alcobra</b><strong> (<a href='http://seekingalpha.com/symbol/adhd' title='Alcobra'>ADHD</a>)</strong>,  an Israeli drug company developing a non-stimulant ADHD treatment,  plans to raise $25 million by offering 2.3 million shares at a price  range of $10.00 to $12.00.   At the midpoint of the proposed range,  Alcobra would command a market value of $113 million.  Alcobra was  founded in 2008.   The Tel Aviv, Israel-based company plans to list on  the Nasdaq under the symbol ADHD. Aegis Capital is the lead bookrunner   on the deal.</p> <p><b>ChannelAdvisor</b><strong> (<a href='http://seekingalpha.com/symbol/ecom' title='ChannelAdvisor'>ECOM</a>)</strong>, which provides an e-commerce platform to manage sales across multiple online channels, plans to raise $75 million by offering 5.8 million shares at a price range of $12.00 to $14.00. At the midpoint of the proposed range, ChannelAdvisor would command a market value of $288 million. ChannelAdvisor, which was founded in 2001, booked $56 million in sales over the last</p>     ]]>
      </content>
      <pubDate>Mon, 20 May 2013 15:58:00 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p> <p><b>Alcobra</b><strong> (<a href='http://seekingalpha.com/symbol/adhd' title='Alcobra'>ADHD</a>)</strong>,  an Israeli drug company developing a non-stimulant ADHD treatment,  plans to raise $25 million by offering 2.3 million shares at a price  range of $10.00 to $12.00.   At the midpoint of the proposed range,  Alcobra would command a market value of $113 million.  Alcobra was  founded in 2008.   The Tel Aviv, Israel-based company plans to list on  the Nasdaq under the symbol ADHD. Aegis Capital is the lead bookrunner   on the deal.</p> <p><b>ChannelAdvisor</b><strong> (<a href='http://seekingalpha.com/symbol/ecom' title='ChannelAdvisor'>ECOM</a>)</strong>, which provides an e-commerce platform to manage sales across multiple online channels, plans to raise $75 million by offering 5.8 million shares at a price range of $12.00 to $14.00. At the midpoint of the proposed range, ChannelAdvisor would command a market value of $288 million. ChannelAdvisor, which was founded in 2001, booked $56 million in sales over the last</p>     <br/><a href='http://seekingalpha.com/article/1448151-6-u-s-ipos-planned-for-the-week-of-may-20?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/adhd">ADHD</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mkto">MKTO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ecom">ECOM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cstm">CSTM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/brss">BRSS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pgem">PGEM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ptla">PTLA</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>U.S. IPO Recap: Marketo And Tableau Soar, May Calendar Stays Full</title>
      <link>http://seekingalpha.com/article/1447391-u-s-ipo-recap-marketo-and-tableau-soar-may-calendar-stays-full?source=feed</link>
      <guid isPermaLink="false">1447391</guid>
      <content>
        <![CDATA[<p>Exactly one year after Facebook (<a href='http://seekingalpha.com/symbol/fb' title='Facebook'>FB</a>) priced its ill-fated IPO, two fast-growing technology companies, Marketo (<a href='http://seekingalpha.com/symbol/mkto' title='Marketo'>MKTO</a>) and Tableau (<a href='http://seekingalpha.com/symbol/data' title='Tableau Software'>DATA</a>),  surged on their first days of trading. Marketo, a marketing software  company, jumped 78% on Friday in the best first-day performance since  Splunk’s (<a href='http://seekingalpha.com/symbol/splk' title='Splunk Inc.'>SPLK</a>)  108% gain in April 2012. With Tableau’s 64% pop, it was just the second  time since 2000 (and the first time since 2010) that two companies  produced first-day gains of more than 50% on the same day. The seven <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOPricings.aspx" rel="nofollow">IPO pricings</a> for the week pushed May’s total to 22, which is the highest monthly total since November 2007. Upcoming <a href="http://www.renaissancecapital.com/IPOHome/Press/MediaRoom.aspx?market=us" rel="nofollow">IPO activity</a> remained strong as well, with four companies setting terms and six making initial filings.</p>  <p/><table border="1">
  <tr><td colspan="5"><b>IPO pricings (week of May 13, 2013)</b></td>         </tr>
  <tr><td><b>Company (Ticker)</b></td>             <td><b>Business</b></td>             <td><b>Deal Size ($mm)</b></td>             <td><b>Price vs. Midpoint</b></td>             <td><b>Return</b></td>         </tr>
  <tr><td>Ambit Biosciences (<a href='http://seekingalpha.com/symbol/ambi' title='Ambit Biosciences'>AMBI</a>)</td>             <td>Early-stage biotech</td>             <td>$65</td>             <td>-43%</td>             <td>-16%</td>         </tr>
  <tr><td>Marketo </td>             <td>Marketing software</td>             <td>$79</td>             <td>8%</td>                      </tr>
</table>              ]]>
      </content>
      <pubDate>Mon, 20 May 2013 12:49:12 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>Exactly one year after Facebook (<a href='http://seekingalpha.com/symbol/fb' title='Facebook'>FB</a>) priced its ill-fated IPO, two fast-growing technology companies, Marketo (<a href='http://seekingalpha.com/symbol/mkto' title='Marketo'>MKTO</a>) and Tableau (<a href='http://seekingalpha.com/symbol/data' title='Tableau Software'>DATA</a>),  surged on their first days of trading. Marketo, a marketing software  company, jumped 78% on Friday in the best first-day performance since  Splunk’s (<a href='http://seekingalpha.com/symbol/splk' title='Splunk Inc.'>SPLK</a>)  108% gain in April 2012. With Tableau’s 64% pop, it was just the second  time since 2000 (and the first time since 2010) that two companies  produced first-day gains of more than 50% on the same day. The seven <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOPricings.aspx" rel="nofollow">IPO pricings</a> for the week pushed May’s total to 22, which is the highest monthly total since November 2007. Upcoming <a href="http://www.renaissancecapital.com/IPOHome/Press/MediaRoom.aspx?market=us" rel="nofollow">IPO activity</a> remained strong as well, with four companies setting terms and six making initial filings.</p>  <p/><table border="1">
  <tr><td colspan="5"><b>IPO pricings (week of May 13, 2013)</b></td>         </tr>
  <tr><td><b>Company (Ticker)</b></td>             <td><b>Business</b></td>             <td><b>Deal Size ($mm)</b></td>             <td><b>Price vs. Midpoint</b></td>             <td><b>Return</b></td>         </tr>
  <tr><td>Ambit Biosciences (<a href='http://seekingalpha.com/symbol/ambi' title='Ambit Biosciences'>AMBI</a>)</td>             <td>Early-stage biotech</td>             <td>$65</td>             <td>-43%</td>             <td>-16%</td>         </tr>
  <tr><td>Marketo </td>             <td>Marketing software</td>             <td>$79</td>             <td>8%</td>                      </tr>
</table>              <br/><a href='http://seekingalpha.com/article/1447391-u-s-ipo-recap-marketo-and-tableau-soar-may-calendar-stays-full?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/mkto">MKTO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/data">DATA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/splk">SPLK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ambi">AMBI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tep">TEP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsre">TSRE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ubic">UBIC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wlh">WLH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tph">TPH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tmhc">TMHC</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>Tableau And Marketo Push May IPO Pricings To 22, Marking Busiest Month Since November 2007</title>
      <link>http://seekingalpha.com/article/1444131-tableau-and-marketo-push-may-ipo-pricings-to-22-marking-busiest-month-since-november-2007?source=feed</link>
      <guid isPermaLink="false">1444131</guid>
      <content>
        <![CDATA[<p>Tableau (<a href='http://seekingalpha.com/symbol/data' title='Tableau Software'>DATA</a>), which sells a data visualization platform, and Marketo (<a href='http://seekingalpha.com/symbol/mkto' title='Marketo'>MKTO</a>), a provider of marketing automation software, priced their IPOs last night, pushing total <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOPricings.aspx" rel="nofollow">IPO pricings </a>in May to 22. That's the most since November 2007, when 26 deals were completed. Earlier, May saw the first 10-IPO week since 2010 and only the second since 2007. With eight companies still on the calendar for May, there is a possibility this month could be the first since May 2007</p>]]>
      </content>
      <pubDate>Fri, 17 May 2013 14:32:24 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>Tableau (<a href='http://seekingalpha.com/symbol/data' title='Tableau Software'>DATA</a>), which sells a data visualization platform, and Marketo (<a href='http://seekingalpha.com/symbol/mkto' title='Marketo'>MKTO</a>), a provider of marketing automation software, priced their IPOs last night, pushing total <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOPricings.aspx" rel="nofollow">IPO pricings </a>in May to 22. That's the most since November 2007, when 26 deals were completed. Earlier, May saw the first 10-IPO week since 2010 and only the second since 2007. With eight companies still on the calendar for May, there is a possibility this month could be the first since May 2007</p><br/><a href='http://seekingalpha.com/article/1444131-tableau-and-marketo-push-may-ipo-pricings-to-22-marking-busiest-month-since-november-2007?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/data">DATA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mkto">MKTO</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>U.S. IPO Recap: 10 Deals Price, Highest Weekly Total Since 2010</title>
      <link>http://seekingalpha.com/article/1430361-u-s-ipo-recap-10-deals-price-highest-weekly-total-since-2010?source=feed</link>
      <guid isPermaLink="false">1430361</guid>
      <content>
        <![CDATA[<p>Deal flow picked up from already high levels, but returns were light in a  ten-IPO week, just the second since 2007. Half of the week’s deals were  from financial companies, while the largest was a $947 million offering  from Quintiles Transnational (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>),  a service provider for biopharmaceutical companies. Activity is poised  to continue with seven newly scheduled deals, including a trio of  fast-growing technology companies. After just a week and a half, May’s  15 pricings are already the highest monthly total since October. With  ten IPOs on the calendar, the final monthly total could exceed 20 for  the first time in more than five years.</p>  <p>
  <b>IPO pricings (week of May 6, 2013)</b>
</p> <p/><table border="1">
  <tr><td>Company </td>             <td>Business</td>             <td>Deal Size ($mm)</td>             <td>Price vs. Midpoint</td>             <td>Return</td>         </tr>
  <tr><td>American Residential Properties (<a href='http://seekingalpha.com/symbol/arpi' title='American Residential Properties'>ARPI</a>)</td>             <td>Residential REIT</td>             <td>$288</td>             <td>-4.5%</td>             <td>0.0%</td>         </tr>
  <tr><td>Armada Hoffler Properties (<a href='http://seekingalpha.com/symbol/ahh' title='Armada Hoffler Properties, Inc.'>AHH</a>)</td>             <td>Commercial REIT</td>             <td>$190</td>             <td>-4.2%</td>             <td>0.9%</td>         </tr>
  <tr><td>BioAmber (<a href='http://seekingalpha.com/symbol/bioa' title='BioAmber'>BIOA</a>)</td>             <td>Renewable chemicals</td>             <td>$80</td>             <td>-37.5%</td>             <td>-16.0%</td>         </tr>
  <tr><td>Cyan (<a href='http://seekingalpha.com/symbol/cyni' title='Cyan Inc.'>CYNI</a>)</td>             <td>Networking solutions</td>                                                </tr>
</table>    ]]>
      </content>
      <pubDate>Mon, 13 May 2013 13:33:40 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>Deal flow picked up from already high levels, but returns were light in a  ten-IPO week, just the second since 2007. Half of the week’s deals were  from financial companies, while the largest was a $947 million offering  from Quintiles Transnational (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>),  a service provider for biopharmaceutical companies. Activity is poised  to continue with seven newly scheduled deals, including a trio of  fast-growing technology companies. After just a week and a half, May’s  15 pricings are already the highest monthly total since October. With  ten IPOs on the calendar, the final monthly total could exceed 20 for  the first time in more than five years.</p>  <p>
  <b>IPO pricings (week of May 6, 2013)</b>
</p> <p/><table border="1">
  <tr><td>Company </td>             <td>Business</td>             <td>Deal Size ($mm)</td>             <td>Price vs. Midpoint</td>             <td>Return</td>         </tr>
  <tr><td>American Residential Properties (<a href='http://seekingalpha.com/symbol/arpi' title='American Residential Properties'>ARPI</a>)</td>             <td>Residential REIT</td>             <td>$288</td>             <td>-4.5%</td>             <td>0.0%</td>         </tr>
  <tr><td>Armada Hoffler Properties (<a href='http://seekingalpha.com/symbol/ahh' title='Armada Hoffler Properties, Inc.'>AHH</a>)</td>             <td>Commercial REIT</td>             <td>$190</td>             <td>-4.2%</td>             <td>0.9%</td>         </tr>
  <tr><td>BioAmber (<a href='http://seekingalpha.com/symbol/bioa' title='BioAmber'>BIOA</a>)</td>             <td>Renewable chemicals</td>             <td>$80</td>             <td>-37.5%</td>             <td>-16.0%</td>         </tr>
  <tr><td>Cyan (<a href='http://seekingalpha.com/symbol/cyni' title='Cyan Inc.'>CYNI</a>)</td>             <td>Networking solutions</td>                                                </tr>
</table>    <br/><a href='http://seekingalpha.com/article/1430361-u-s-ipo-recap-10-deals-price-highest-weekly-total-since-2010?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/q">Q</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/arpi">ARPI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ahh">AHH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bioa">BIOA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cyni">CYNI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/emes">EMES</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nbcb">NBCB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pfsi">PFSI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/rcpt">RCPT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsc">TSC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mkto">MKTO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/rcap">RCAP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/data">DATA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tep">TEP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wlh">WLH</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>7 U.S. IPOs Planned For The Week Of May 13</title>
      <link>http://seekingalpha.com/article/1429331-7-u-s-ipos-planned-for-the-week-of-may-13?source=feed</link>
      <guid isPermaLink="false">1429331</guid>
      <content>
        <![CDATA[<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p>  <p><b>Ambit Biosciences</b> (<a href='http://seekingalpha.com/symbol/ambi' title='Ambit Biosciences'>AMBI</a>),  which is developing small molecule therapeutics for the treatment of  acute myeloid leukemia, plans to raise $65 million by offering 4.6  million shares at a price range of $13.00 to $15.00.   At the midpoint  of the proposed range, Ambit Biosciences would command a market value of  $180 million.  Ambit Biosciences, which was founded in 2000, booked $19  million in sales over the last 12 months.   The San Diego, CA-based  company plans to list on the NASDAQ under the symbol AMBI.  Citi,  Leerink Swann and BMO Capital Markets are the joint bookrunners  on the  deal.</p>  <p><b>Marketo</b> (<a href='http://seekingalpha.com/symbol/mkto' title='Marketo'>MKTO</a>), which provides on-demand marketing software to SMBs and enterprises, plans to raise $73 million by offering 6.1 million shares at a price range of $11.00 to $13.00. At the midpoint of the proposed range, Marketo would command a market</p>              ]]>
      </content>
      <pubDate>Mon, 13 May 2013 09:15:03 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p>  <p><b>Ambit Biosciences</b> (<a href='http://seekingalpha.com/symbol/ambi' title='Ambit Biosciences'>AMBI</a>),  which is developing small molecule therapeutics for the treatment of  acute myeloid leukemia, plans to raise $65 million by offering 4.6  million shares at a price range of $13.00 to $15.00.   At the midpoint  of the proposed range, Ambit Biosciences would command a market value of  $180 million.  Ambit Biosciences, which was founded in 2000, booked $19  million in sales over the last 12 months.   The San Diego, CA-based  company plans to list on the NASDAQ under the symbol AMBI.  Citi,  Leerink Swann and BMO Capital Markets are the joint bookrunners  on the  deal.</p>  <p><b>Marketo</b> (<a href='http://seekingalpha.com/symbol/mkto' title='Marketo'>MKTO</a>), which provides on-demand marketing software to SMBs and enterprises, plans to raise $73 million by offering 6.1 million shares at a price range of $11.00 to $13.00. At the midpoint of the proposed range, Marketo would command a market</p>              <br/><a href='http://seekingalpha.com/article/1429331-7-u-s-ipos-planned-for-the-week-of-may-13?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/ambi">AMBI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mkto">MKTO</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/data">DATA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tep">TEP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsre">TSRE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ubic">UBIC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wlh">WLH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsc">TSC</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>7 IPOs Debut On Thursday, Most In A Single Day Since 2004</title>
      <link>http://seekingalpha.com/article/1423341-7-ipos-debut-on-thursday-most-in-a-single-day-since-2004?source=feed</link>
      <guid isPermaLink="false">1423341</guid>
      <content>
        <![CDATA[<p>Seven deals began trading on Thursday, marking  the most IPOs to debut in a day since December 15, 2004. Thursday's  group included single-family residential REIT American Residential  Properties (<a href='http://seekingalpha.com/symbol/arpi' title='American Residential Properties'>ARPI</a>), packet-optical networking vendor Cyan (<a href='http://seekingalpha.com/symbol/cyni' title='Cyan Inc.'>CYNI</a>), frac sand LP Emerge Energy Services (<a href='http://seekingalpha.com/symbol/emes' title='Emerge Energy'>EMES</a>), mortgage producer and servicer PennyMac Financial Services (<a href='http://seekingalpha.com/symbol/pfsi' title='PennyMac Financial Services'>PFSI</a>), the world's largest contract research organization Quintiles Transnational (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>), biotech Receptos (<a href='http://seekingalpha.com/symbol/rcpt' title='Receptos, Inc.'>RCPT</a>), and branchless bank TriState Capital (<a href='http://seekingalpha.com/symbol/tsc' title='TriState Capital'>TSC</a>).</p>  <p>TriState Capital was the best performing deal, finishing the day up  9.5%. Receptos (traded flat), American Residential Properties (flat)   and Emerge Energy Services (-2.7%) all priced below the midpoint and  failed to gain traction throughout the day.</p>  <p>
  <b>Quintiles and Receptos price upsized deals at opposite ends of the range</b>
</p> <p>Quintiles, the world’s largest CRO and provider of commercial outsourcing services to biopharmas, raised $947 million by offering 23.7 million shares (45% insider) at $40, the top of the $36 to $40 range. The</p>                   ]]>
      </content>
      <pubDate>Fri, 10 May 2013 07:34:26 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>Seven deals began trading on Thursday, marking  the most IPOs to debut in a day since December 15, 2004. Thursday's  group included single-family residential REIT American Residential  Properties (<a href='http://seekingalpha.com/symbol/arpi' title='American Residential Properties'>ARPI</a>), packet-optical networking vendor Cyan (<a href='http://seekingalpha.com/symbol/cyni' title='Cyan Inc.'>CYNI</a>), frac sand LP Emerge Energy Services (<a href='http://seekingalpha.com/symbol/emes' title='Emerge Energy'>EMES</a>), mortgage producer and servicer PennyMac Financial Services (<a href='http://seekingalpha.com/symbol/pfsi' title='PennyMac Financial Services'>PFSI</a>), the world's largest contract research organization Quintiles Transnational (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>), biotech Receptos (<a href='http://seekingalpha.com/symbol/rcpt' title='Receptos, Inc.'>RCPT</a>), and branchless bank TriState Capital (<a href='http://seekingalpha.com/symbol/tsc' title='TriState Capital'>TSC</a>).</p>  <p>TriState Capital was the best performing deal, finishing the day up  9.5%. Receptos (traded flat), American Residential Properties (flat)   and Emerge Energy Services (-2.7%) all priced below the midpoint and  failed to gain traction throughout the day.</p>  <p>
  <b>Quintiles and Receptos price upsized deals at opposite ends of the range</b>
</p> <p>Quintiles, the world’s largest CRO and provider of commercial outsourcing services to biopharmas, raised $947 million by offering 23.7 million shares (45% insider) at $40, the top of the $36 to $40 range. The</p>                   <br/><a href='http://seekingalpha.com/article/1423341-7-ipos-debut-on-thursday-most-in-a-single-day-since-2004?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/arpi">ARPI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cyni">CYNI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/emes">EMES</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pfsi">PFSI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/q">Q</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/rcpt">RCPT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsc">TSC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ahh">AHH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wday">WDAY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/rlgy">RLGY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/sstk">SSTK</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>13 U.S. IPOs Planned For The Week Of May 6</title>
      <link>http://seekingalpha.com/article/1406381-13-u-s-ipos-planned-for-the-week-of-may-6?source=feed</link>
      <guid isPermaLink="false">1406381</guid>
      <content>
        <![CDATA[<p><br/>                 The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p> <p><b>American Residential Properties</b> (<a href='http://seekingalpha.com/symbol/arpi' title='American Residential Properties'>ARPI</a>),  an internally managed REIT focused on leasing single-family residential  properties, plans to raise $301 million by offering 13.7 million shares  at a price range of $21.00 to $23.00.   At the midpoint of the proposed  range, American Residential Properties would command a market value of  $731 million.  American Residential Properties, which was founded in  2008, booked $3 million in sales over the last 12 months.   The  Scottsdale, AZ-based company plans to list on the NYSE under the symbol  ARPI.  Morgan Stanley, BofA Merrill Lynch, FBR Capital Markets and  Jefferies &amp; Co. are the joint book runners  on the deal.</p><p><b>Armada Hoffler Properties</b> (<a href='http://seekingalpha.com/symbol/ahh' title='Armada Hoffler Properties, Inc.'>AHH</a>), a REIT that develops, builds and owns office, retail and multifamily properties, plans to raise $175 million by offering 14.6 million shares at a price range of $11.00 to $13.00. At</p>]]>
      </content>
      <pubDate>Mon, 06 May 2013 15:04:52 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p><br/>                 The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p> <p><b>American Residential Properties</b> (<a href='http://seekingalpha.com/symbol/arpi' title='American Residential Properties'>ARPI</a>),  an internally managed REIT focused on leasing single-family residential  properties, plans to raise $301 million by offering 13.7 million shares  at a price range of $21.00 to $23.00.   At the midpoint of the proposed  range, American Residential Properties would command a market value of  $731 million.  American Residential Properties, which was founded in  2008, booked $3 million in sales over the last 12 months.   The  Scottsdale, AZ-based company plans to list on the NYSE under the symbol  ARPI.  Morgan Stanley, BofA Merrill Lynch, FBR Capital Markets and  Jefferies &amp; Co. are the joint book runners  on the deal.</p><p><b>Armada Hoffler Properties</b> (<a href='http://seekingalpha.com/symbol/ahh' title='Armada Hoffler Properties, Inc.'>AHH</a>), a REIT that develops, builds and owns office, retail and multifamily properties, plans to raise $175 million by offering 14.6 million shares at a price range of $11.00 to $13.00. At</p><br/><a href='http://seekingalpha.com/article/1406381-13-u-s-ipos-planned-for-the-week-of-may-6?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/ahh">AHH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bioa">BIOA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cyni">CYNI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/q">Q</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/rcpt">RCPT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsre">TSRE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsc">TSC</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>U.S. IPO Recap: Activity Remains Robust With 5 Pricings, 5 Setting Terms And 4 New Filers</title>
      <link>http://seekingalpha.com/article/1405481-u-s-ipo-recap-activity-remains-robust-with-5-pricings-5-setting-terms-and-4-new-filers?source=feed</link>
      <guid isPermaLink="false">1405481</guid>
      <content>
        <![CDATA[<p>Following last week's market break, U.S. IPO activity resumed where it left off last week with five pricings, including ING U.S. (<a href='http://seekingalpha.com/symbol/voya' title='ING U.S. '>VOYA</a>),  which raised $1.3 billion. However, overall performance was subpar,  with four of five of the deals achieving a total return of 6% or less  and three of five IPOs failing to achieve a 1% first-day pop despite  pricing sensitivity (three deals priced below the range). New deal  activity, though, remained robust as five companies were added to the  calendar, including American Residential Properties (<a href='http://seekingalpha.com/symbol/anrpz.ob' title='American Residential Properties Inc'>ANRPZ.OB</a>),  which is looking to raise $301 million and become the second single  family-focused REIT to list this year. Last week also saw four new  filers, most notably Apollo-backed teen jewelry retailer Claire's (<a href='http://seekingalpha.com/symbol/clea.pk' title='Claire Technologies'>CLEA.PK</a>), which filed for an IPO that we estimate could raise as much as $500 million.</p> <p>
  <b>ING U.S. marks second US IPO to raise over $1 billion in 2013</b>
</p> <p>ING U.S., ING's</p>             ]]>
      </content>
      <pubDate>Mon, 06 May 2013 11:32:01 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>Following last week's market break, U.S. IPO activity resumed where it left off last week with five pricings, including ING U.S. (<a href='http://seekingalpha.com/symbol/voya' title='ING U.S. '>VOYA</a>),  which raised $1.3 billion. However, overall performance was subpar,  with four of five of the deals achieving a total return of 6% or less  and three of five IPOs failing to achieve a 1% first-day pop despite  pricing sensitivity (three deals priced below the range). New deal  activity, though, remained robust as five companies were added to the  calendar, including American Residential Properties (<a href='http://seekingalpha.com/symbol/anrpz.ob' title='American Residential Properties Inc'>ANRPZ.OB</a>),  which is looking to raise $301 million and become the second single  family-focused REIT to list this year. Last week also saw four new  filers, most notably Apollo-backed teen jewelry retailer Claire's (<a href='http://seekingalpha.com/symbol/clea.pk' title='Claire Technologies'>CLEA.PK</a>), which filed for an IPO that we estimate could raise as much as $500 million.</p> <p>
  <b>ING U.S. marks second US IPO to raise over $1 billion in 2013</b>
</p> <p>ING U.S., ING's</p>             <br/><a href='http://seekingalpha.com/article/1405481-u-s-ipo-recap-activity-remains-robust-with-5-pricings-5-setting-terms-and-4-new-filers?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/voya">VOYA</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/anrpz.ob">ANRPZ.OB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/clea.pk">CLEA.PK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/qiwi">QIWI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/earn">EARN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/insy">INSY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/gwph">GWPH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/pfsi">PFSI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/arpi">ARPI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/emes">EMES</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nbcb">NBCB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ambi">AMBI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/chmi">CHMI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hart">HART</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>U.S. IPO Recap: Quintiles, 5 Others Set Terms</title>
      <link>http://seekingalpha.com/article/1381561-u-s-ipo-recap-quintiles-5-others-set-terms?source=feed</link>
      <guid isPermaLink="false">1381561</guid>
      <content>
        <![CDATA[<p>Despite no new pricings or filings, the U.S. IPO market remained active  last week as six companies launched deals. Most of the $1.3 billion in  proceeds added to the calendar came from biopharmaceutical service  provider Quintiles (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>), which is seeking $750 million. Aside from very fast growing tech company Cyan (<a href='http://seekingalpha.com/symbol/cyni' title='Cyan Inc.'>CYNI</a>),  the remaining new deals were smaller, niche offerings, including two  REITs, a development-stage biotech and a regional bank. There are now a  total of 14 deals on the <a href="http://www.renaissancecapital.com/IPOHome/Calendars/OnDeck.aspx" rel="nofollow">IPO calendar</a>.<br/><br/><b>Drug-trial operator Quintiles sets terms for $750 million IPO</b><br/> Quintiles Transnational, the largest provider of clinical trial services to pharmaceutical companies, announced that it plans to raise $750 million by offering 19.7 million shares (30% insider) at a price range of $36 to $40. The $750 deal size would make Quintiles the third largest IPO of 2013, behind Zoetis (<a href='http://seekingalpha.com/symbol/zts' title='Zoetis'>ZTS</a>), which raised $2.2 billion, and ING US</p>]]>
      </content>
      <pubDate>Mon, 29 Apr 2013 13:06:55 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>Despite no new pricings or filings, the U.S. IPO market remained active  last week as six companies launched deals. Most of the $1.3 billion in  proceeds added to the calendar came from biopharmaceutical service  provider Quintiles (<a href='http://seekingalpha.com/symbol/q' title='Quintiles'>Q</a>), which is seeking $750 million. Aside from very fast growing tech company Cyan (<a href='http://seekingalpha.com/symbol/cyni' title='Cyan Inc.'>CYNI</a>),  the remaining new deals were smaller, niche offerings, including two  REITs, a development-stage biotech and a regional bank. There are now a  total of 14 deals on the <a href="http://www.renaissancecapital.com/IPOHome/Calendars/OnDeck.aspx" rel="nofollow">IPO calendar</a>.<br/><br/><b>Drug-trial operator Quintiles sets terms for $750 million IPO</b><br/> Quintiles Transnational, the largest provider of clinical trial services to pharmaceutical companies, announced that it plans to raise $750 million by offering 19.7 million shares (30% insider) at a price range of $36 to $40. The $750 deal size would make Quintiles the third largest IPO of 2013, behind Zoetis (<a href='http://seekingalpha.com/symbol/zts' title='Zoetis'>ZTS</a>), which raised $2.2 billion, and ING US</p><br/><a href='http://seekingalpha.com/article/1381561-u-s-ipo-recap-quintiles-5-others-set-terms?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/cyni">CYNI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/earn">EARN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/rcpt">RCPT</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tsc">TSC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/q">Q</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>6 U.S. IPOs Planned For The Week Of April 29</title>
      <link>http://seekingalpha.com/article/1381081-6-u-s-ipos-planned-for-the-week-of-april-29?source=feed</link>
      <guid isPermaLink="false">1381081</guid>
      <content>
        <![CDATA[<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p> <p><b>BioAmber</b> &#40;BIOA&#41;,  which converts renewable feedstocks into bio-succinic acid and other  chemicals, plans to raise $128 million by offering 8.0 million shares at  a price range of $15.00 to $17.00.   At the midpoint of the proposed  range, BioAmber would command a market value of $325 million.  BioAmber,  which was founded in 2008, booked $2 million in sales over the last 12  months.   The Montreal, Canada-based company plans to list on the NYSE  under the symbol BIOA.  Credit Suisse, Societe Generale and Barclays are  the joint book runners  on the deal. </p>   <p><b>Ellington Residential Mortgage REIT</b> &#40;EARN&#41;, a mortgage REIT that invests in Agency RMBS and non-Agency RMBS, plans to raise $129 million by offering 6.5 million shares at a price range of $20.00 to $20.00. At the midpoint of the proposed range, Ellington Residential Mortgage REIT would command a</p>        ]]>
      </content>
      <pubDate>Mon, 29 Apr 2013 10:36:26 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p> <p><b>BioAmber</b> &#40;BIOA&#41;,  which converts renewable feedstocks into bio-succinic acid and other  chemicals, plans to raise $128 million by offering 8.0 million shares at  a price range of $15.00 to $17.00.   At the midpoint of the proposed  range, BioAmber would command a market value of $325 million.  BioAmber,  which was founded in 2008, booked $2 million in sales over the last 12  months.   The Montreal, Canada-based company plans to list on the NYSE  under the symbol BIOA.  Credit Suisse, Societe Generale and Barclays are  the joint book runners  on the deal. </p>   <p><b>Ellington Residential Mortgage REIT</b> &#40;EARN&#41;, a mortgage REIT that invests in Agency RMBS and non-Agency RMBS, plans to raise $129 million by offering 6.5 million shares at a price range of $20.00 to $20.00. At the midpoint of the proposed range, Ellington Residential Mortgage REIT would command a</p>        <br/><a href='http://seekingalpha.com/article/1381081-6-u-s-ipos-planned-for-the-week-of-april-29?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/gwph">GWPH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/qiwi">QIWI</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>U.S. IPO Recap: Fairway Jumps 45% In 6-Deal Week</title>
      <link>http://seekingalpha.com/article/1358271-u-s-ipo-recap-fairway-jumps-45-in-6-deal-week?source=feed</link>
      <guid isPermaLink="false">1358271</guid>
      <content>
        <![CDATA[<p>The successful IPOs of Fairway Group (<a href='http://seekingalpha.com/symbol/fwm' title='Fairway Group'>FWM</a>), Blackhawk Network (<a href='http://seekingalpha.com/symbol/hawk' title='Blackhawk Network Holdings, Inc.'>HAWK</a>) and SeaWorld Entertainment (<a href='http://seekingalpha.com/symbol/seas' title='SeaWorld Entertainment Inc.'>SEAS</a>) served as positive bookends to a mixed week in the US IPO market. For the second week in a row, six IPOs priced, but Thursday's three deals from Taminco (<a href='http://seekingalpha.com/symbol/tam' title='Taminco Corporation'>TAM</a>), Intelsat (<a href='http://seekingalpha.com/symbol/i' title='Intelsat SA'>I</a>) and Hannon Armstrong (<a href='http://seekingalpha.com/symbol/hasi' title='Hannon Armstrong Sustainable Infrastructure Capital'>HASI</a>) all raised much less than expected and produced lackluster returns. ING U.S.'s &#40;VOYA&#41; planned $1.4 billion IPO was the most prominent of four deals added to the <a href="http://www.renaissancecapital.com/IPOHome/Calendars/OnDeck.aspx" rel="nofollow">IPO calendar</a>. The week also saw four new filings, which included a $5.4 billion deal from Brazil's Votorantim Cimentos &#40;VOTO.RC&#41; and the first filing from China since YY (<a href='http://seekingalpha.com/symbol/yy' title='YY Inc.'>YY</a>) in October 2012.</p>  <p>
  <b>New York City grocer Fairway Group jumps 33%</b>
</p> <p>Fairway Group, which operates 12 large-format grocery stores in the greater NYC metro area, raised $177 million by offering 13.7 million shares at $13, above the $10 to $12 range. Fairway soared</p>                                    ]]>
      </content>
      <pubDate>Mon, 22 Apr 2013 11:11:40 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>The successful IPOs of Fairway Group (<a href='http://seekingalpha.com/symbol/fwm' title='Fairway Group'>FWM</a>), Blackhawk Network (<a href='http://seekingalpha.com/symbol/hawk' title='Blackhawk Network Holdings, Inc.'>HAWK</a>) and SeaWorld Entertainment (<a href='http://seekingalpha.com/symbol/seas' title='SeaWorld Entertainment Inc.'>SEAS</a>) served as positive bookends to a mixed week in the US IPO market. For the second week in a row, six IPOs priced, but Thursday's three deals from Taminco (<a href='http://seekingalpha.com/symbol/tam' title='Taminco Corporation'>TAM</a>), Intelsat (<a href='http://seekingalpha.com/symbol/i' title='Intelsat SA'>I</a>) and Hannon Armstrong (<a href='http://seekingalpha.com/symbol/hasi' title='Hannon Armstrong Sustainable Infrastructure Capital'>HASI</a>) all raised much less than expected and produced lackluster returns. ING U.S.'s &#40;VOYA&#41; planned $1.4 billion IPO was the most prominent of four deals added to the <a href="http://www.renaissancecapital.com/IPOHome/Calendars/OnDeck.aspx" rel="nofollow">IPO calendar</a>. The week also saw four new filings, which included a $5.4 billion deal from Brazil's Votorantim Cimentos &#40;VOTO.RC&#41; and the first filing from China since YY (<a href='http://seekingalpha.com/symbol/yy' title='YY Inc.'>YY</a>) in October 2012.</p>  <p>
  <b>New York City grocer Fairway Group jumps 33%</b>
</p> <p>Fairway Group, which operates 12 large-format grocery stores in the greater NYC metro area, raised $177 million by offering 13.7 million shares at $13, above the $10 to $12 range. Fairway soared</p>                                    <br/><a href='http://seekingalpha.com/article/1358271-u-s-ipo-recap-fairway-jumps-45-in-6-deal-week?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/hawk">HAWK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/seas">SEAS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/i">I</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hasi">HASI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fwm">FWM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tam">TAM</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>3 Deals Trade Poorly In Debuts After Pricing Well Below The Range</title>
      <link>http://seekingalpha.com/article/1352921-3-deals-trade-poorly-in-debuts-after-pricing-well-below-the-range?source=feed</link>
      <guid isPermaLink="false">1352921</guid>
      <content>
        <![CDATA[<p>For the third time in as many months, three deals debuted on the same day. The February trio -- mortgage REIT Zais Financial (<a href='http://seekingalpha.com/symbol/zfc' title='ZAIS Financial'>ZFC</a>) at -6.1%, LP New Source Energy (<a href='http://seekingalpha.com/symbol/nslp' title='New Source Energy Partners'>NSLP</a>) at -2.6%, and medical insurance provider Health Insurance Innovations (<a href='http://seekingalpha.com/symbol/hiiq' title='Health Insurance Innovations'>HIIQ</a>) at  -2.1% -- performed poorly on their first day of trading. The March group  did not fare much better, as communications company West Corp. (<a href='http://seekingalpha.com/symbol/wstc' title='West Corporation'>WSTC</a>) at -5.7% and mortgage REIT Five Oaks Investment (<a href='http://seekingalpha.com/symbol/foic' title='Five Oaks Investment'>FOIC</a>) at -3.3% traded down in their debuts. However, on-demand ad management firm Marin Software (<a href='http://seekingalpha.com/symbol/mrin' title='Marin Software'>MRIN</a>) at 16.1% attempted to redeem the group.</p> <p>Although the April threesome of chemical producer Taminco (<a href='http://seekingalpha.com/symbol/tam' title='Taminco Corporation'>TAM</a>), clean energy REIT Hannon Armstrong (<a href='http://seekingalpha.com/symbol/hasi' title='Hannon Armstrong Sustainable Infrastructure Capital'>HASI</a>), and satellite services provider Intelsat (<a href='http://seekingalpha.com/symbol/i' title='Intelsat SA'>I</a>) hoped for a different fate, they failed to escape the trend. After all three companies priced well below the range, Taminco (-4.7%) and Hannon Armstrong (-9.2%) both fell and Intelsat (4.0%) traded</p>     ]]>
      </content>
      <pubDate>Thu, 18 Apr 2013 17:11:24 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>For the third time in as many months, three deals debuted on the same day. The February trio -- mortgage REIT Zais Financial (<a href='http://seekingalpha.com/symbol/zfc' title='ZAIS Financial'>ZFC</a>) at -6.1%, LP New Source Energy (<a href='http://seekingalpha.com/symbol/nslp' title='New Source Energy Partners'>NSLP</a>) at -2.6%, and medical insurance provider Health Insurance Innovations (<a href='http://seekingalpha.com/symbol/hiiq' title='Health Insurance Innovations'>HIIQ</a>) at  -2.1% -- performed poorly on their first day of trading. The March group  did not fare much better, as communications company West Corp. (<a href='http://seekingalpha.com/symbol/wstc' title='West Corporation'>WSTC</a>) at -5.7% and mortgage REIT Five Oaks Investment (<a href='http://seekingalpha.com/symbol/foic' title='Five Oaks Investment'>FOIC</a>) at -3.3% traded down in their debuts. However, on-demand ad management firm Marin Software (<a href='http://seekingalpha.com/symbol/mrin' title='Marin Software'>MRIN</a>) at 16.1% attempted to redeem the group.</p> <p>Although the April threesome of chemical producer Taminco (<a href='http://seekingalpha.com/symbol/tam' title='Taminco Corporation'>TAM</a>), clean energy REIT Hannon Armstrong (<a href='http://seekingalpha.com/symbol/hasi' title='Hannon Armstrong Sustainable Infrastructure Capital'>HASI</a>), and satellite services provider Intelsat (<a href='http://seekingalpha.com/symbol/i' title='Intelsat SA'>I</a>) hoped for a different fate, they failed to escape the trend. After all three companies priced well below the range, Taminco (-4.7%) and Hannon Armstrong (-9.2%) both fell and Intelsat (4.0%) traded</p>     <br/><a href='http://seekingalpha.com/article/1352921-3-deals-trade-poorly-in-debuts-after-pricing-well-below-the-range?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/zfc">ZFC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nslp">NSLP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hiiq">HIIQ</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wstc">WSTC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/foic">FOIC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mrin">MRIN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hasi">HASI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/i">I</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bfam">BFAM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bcc">BCC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fwm">FWM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hawk">HAWK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/seas">SEAS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tam">TAM</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>Fairway Soars 33% In Trading Debut, 4th Best Of 2013</title>
      <link>http://seekingalpha.com/article/1350581-fairway-soars-33-in-trading-debut-4th-best-of-2013?source=feed</link>
      <guid isPermaLink="false">1350581</guid>
      <content>
        <![CDATA[<p>Fairway (<a href='http://seekingalpha.com/symbol/fwm' title='Fairway Group'>FWM</a>) soared 33% in trading today as investors ate up the high-growth story, making the greater NYC area grocery store chain the 4th best debut of 2013. Fairway also represents the first IPO from the retail sector</p>     ]]>
      </content>
      <pubDate>Thu, 18 Apr 2013 08:57:07 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>Fairway (<a href='http://seekingalpha.com/symbol/fwm' title='Fairway Group'>FWM</a>) soared 33% in trading today as investors ate up the high-growth story, making the greater NYC area grocery store chain the 4th best debut of 2013. Fairway also represents the first IPO from the retail sector</p>     <br/><a href='http://seekingalpha.com/article/1350581-fairway-soars-33-in-trading-debut-4th-best-of-2013?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/fwm">FWM</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>U.S. IPO Recap: 6 Deals Price In Another Strong Week For Filings</title>
      <link>http://seekingalpha.com/article/1342001-u-s-ipo-recap-6-deals-price-in-another-strong-week-for-filings?source=feed</link>
      <guid isPermaLink="false">1342001</guid>
      <content>
        <![CDATA[<p>Led by two large deals from Puerto Rican transaction processor EVERTEC (<a href='http://seekingalpha.com/symbol/evtc' title='EVERTEC'>EVTC</a>) and homebuilder Taylor Morrison (<a href='http://seekingalpha.com/symbol/tmhc' title='Taylor Morrison'>TMHC</a>), <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOPricings.aspx" rel="nofollow">six US IPOs</a> raised a total of more than $1.5 billion last week. All but one traded up, and two, biotech Chimerix (<a href='http://seekingalpha.com/symbol/cmrx' title='Chimerix'>CMRX</a>) and enterprise SaaS company Rally Software (<a href='http://seekingalpha.com/symbol/raly' title='Rally Software'>RALY</a>), gained more than 25%. Four new deals were added to the <a href="http://www.renaissancecapital.com/IPOHome/Calendars/OnDeck.aspx" rel="nofollow">IPO calendar</a>, and some big names such as SeaWorld (<a href='http://seekingalpha.com/symbol/seas' title='SeaWorld Entertainment Inc.'>SEAS</a>) and Blackhawk Network (<a href='http://seekingalpha.com/symbol/hawk' title='Blackhawk Network Holdings, Inc.'>HAWK</a>) are scheduled to price this week. A new $1 billion deal from private equity-backed industrial distribution company HD Supply &#40;HDS.RC&#41; helped to sustain a surge in new <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOFilings.aspx" rel="nofollow">IPO filings</a>.  Including seven last week, 15 companies have filed so far in  April, which is already tied for the highest monthly total since August.<br/><br/><b>Rally jumps 27% in latest successful enterprise SaaS debut</b><br/> Rally Software, which provides cloud software to manage Agile-based software development, raised $84</p>]]>
      </content>
      <pubDate>Mon, 15 Apr 2013 12:06:38 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>Led by two large deals from Puerto Rican transaction processor EVERTEC (<a href='http://seekingalpha.com/symbol/evtc' title='EVERTEC'>EVTC</a>) and homebuilder Taylor Morrison (<a href='http://seekingalpha.com/symbol/tmhc' title='Taylor Morrison'>TMHC</a>), <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOPricings.aspx" rel="nofollow">six US IPOs</a> raised a total of more than $1.5 billion last week. All but one traded up, and two, biotech Chimerix (<a href='http://seekingalpha.com/symbol/cmrx' title='Chimerix'>CMRX</a>) and enterprise SaaS company Rally Software (<a href='http://seekingalpha.com/symbol/raly' title='Rally Software'>RALY</a>), gained more than 25%. Four new deals were added to the <a href="http://www.renaissancecapital.com/IPOHome/Calendars/OnDeck.aspx" rel="nofollow">IPO calendar</a>, and some big names such as SeaWorld (<a href='http://seekingalpha.com/symbol/seas' title='SeaWorld Entertainment Inc.'>SEAS</a>) and Blackhawk Network (<a href='http://seekingalpha.com/symbol/hawk' title='Blackhawk Network Holdings, Inc.'>HAWK</a>) are scheduled to price this week. A new $1 billion deal from private equity-backed industrial distribution company HD Supply &#40;HDS.RC&#41; helped to sustain a surge in new <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOFilings.aspx" rel="nofollow">IPO filings</a>.  Including seven last week, 15 companies have filed so far in  April, which is already tied for the highest monthly total since August.<br/><br/><b>Rally jumps 27% in latest successful enterprise SaaS debut</b><br/> Rally Software, which provides cloud software to manage Agile-based software development, raised $84</p><br/><a href='http://seekingalpha.com/article/1342001-u-s-ipo-recap-6-deals-price-in-another-strong-week-for-filings?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/evtc">EVTC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tmhc">TMHC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cmrx">CMRX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/raly">RALY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/seas">SEAS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hawk">HAWK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/omth">OMTH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/knop">KNOP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cnob">CNOB</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ibtx">IBTX</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>6 U.S. IPOs Planned For The Week Of April 15</title>
      <link>http://seekingalpha.com/article/1341611-6-u-s-ipos-planned-for-the-week-of-april-15?source=feed</link>
      <guid isPermaLink="false">1341611</guid>
      <content>
        <![CDATA[<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p>  <p><b>Blackhawk Network</b> (<a href='http://seekingalpha.com/symbol/hawk' title='Blackhawk Network Holdings, Inc.'>HAWK</a>),  a Safeway spinoff that distributes prepaid gift, telecom and debit  cards, plans to raise $210 million by offering 10.0 million shares at a  price range of $20.00 to $22.00.   At the midpoint of the proposed  range, Blackhawk Network would command a market value of $1.1 billion.   Blackhawk Network, which was founded in 2001, booked $959 million in  sales over the last 12 months.   The Pleasanton, CA-based company plans  to list on the NASDAQ under the symbol HAWK.  Goldman Sachs, BofA  Merrill Lynch, Citi and Deutsche Bank are the joint bookrunners  on the  deal.</p>  <p><b>Fairway Group Holdings</b> (<a href='http://seekingalpha.com/symbol/fwm' title='Fairway Group'>FWM</a>), which operates 12 large-format grocery stores in the greater NYC metro area, plans to raise $150 million by offering 13.7 million shares at a price range of $10.00 to $12.00. At the midpoint of the proposed range, Fairway</p>          ]]>
      </content>
      <pubDate>Mon, 15 Apr 2013 10:03:40 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p>  <p><b>Blackhawk Network</b> (<a href='http://seekingalpha.com/symbol/hawk' title='Blackhawk Network Holdings, Inc.'>HAWK</a>),  a Safeway spinoff that distributes prepaid gift, telecom and debit  cards, plans to raise $210 million by offering 10.0 million shares at a  price range of $20.00 to $22.00.   At the midpoint of the proposed  range, Blackhawk Network would command a market value of $1.1 billion.   Blackhawk Network, which was founded in 2001, booked $959 million in  sales over the last 12 months.   The Pleasanton, CA-based company plans  to list on the NASDAQ under the symbol HAWK.  Goldman Sachs, BofA  Merrill Lynch, Citi and Deutsche Bank are the joint bookrunners  on the  deal.</p>  <p><b>Fairway Group Holdings</b> (<a href='http://seekingalpha.com/symbol/fwm' title='Fairway Group'>FWM</a>), which operates 12 large-format grocery stores in the greater NYC metro area, plans to raise $150 million by offering 13.7 million shares at a price range of $10.00 to $12.00. At the midpoint of the proposed range, Fairway</p>          <br/><a href='http://seekingalpha.com/article/1341611-6-u-s-ipos-planned-for-the-week-of-april-15?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/hawk">HAWK</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fwm">FWM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hasi">HASI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/i">I</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/seas">SEAS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cmrx">CMRX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tam">TAM</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>Chimerix Stock Soars As 2 Biotechs Debut Thursday</title>
      <link>http://seekingalpha.com/article/1336511-chimerix-stock-soars-as-2-biotechs-debut-thursday?source=feed</link>
      <guid isPermaLink="false">1336511</guid>
      <content>
        <![CDATA[<p>Two biotechs, Chimerix (<a href='http://seekingalpha.com/symbol/cmrx' title='Chimerix'>CMRX</a>) and Omthera Pharmaceuticals (<a href='http://seekingalpha.com/symbol/omth' title='Omthera Pharmaceuticals'>OMTH</a>), debuted  on Thursday, bringing the total to five deals that have priced in  April. Chimerix finished the day up 34.2% and Omthera traded down  7.1%. The companies joined U.K.-based shuttle tanker operator KNOT  Offshore Partners LP (<a href='http://seekingalpha.com/symbol/knop' title='KNOT Offshore Partners LP'>KNOP</a>), up 3.8%, homebuilder Taylor Morrison (<a href='http://seekingalpha.com/symbol/tmhc' title='Taylor Morrison'>TMHC</a>), up 4.7%, and Texas-based Independent Bank Group (<a href='http://seekingalpha.com/symbol/ibtx' title='Independent Bank Group'>IBTX</a>), up 17.9%, in the growing group of April deals. Eight deals remain on the calendar for the rest of April.</p><p>
  <b>Chimerix Stock Rises After Pricing Upsized Deal</b>
</p><p>Chimerix, which is developing a potent antiviral drug for use in stem cell transplants, raised $102 million by offering 7.3 million shares at $14, within the range of $13 to $15. The Durham, N.C.-based company had originally planned to raise $85 million by offering 6.1 million shares before upsizing the Nasdaq-listed deal by 20%. Aisling Capital agreed to purchase $15 million of shares on</p>]]>
      </content>
      <pubDate>Thu, 11 Apr 2013 18:46:22 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>Two biotechs, Chimerix (<a href='http://seekingalpha.com/symbol/cmrx' title='Chimerix'>CMRX</a>) and Omthera Pharmaceuticals (<a href='http://seekingalpha.com/symbol/omth' title='Omthera Pharmaceuticals'>OMTH</a>), debuted  on Thursday, bringing the total to five deals that have priced in  April. Chimerix finished the day up 34.2% and Omthera traded down  7.1%. The companies joined U.K.-based shuttle tanker operator KNOT  Offshore Partners LP (<a href='http://seekingalpha.com/symbol/knop' title='KNOT Offshore Partners LP'>KNOP</a>), up 3.8%, homebuilder Taylor Morrison (<a href='http://seekingalpha.com/symbol/tmhc' title='Taylor Morrison'>TMHC</a>), up 4.7%, and Texas-based Independent Bank Group (<a href='http://seekingalpha.com/symbol/ibtx' title='Independent Bank Group'>IBTX</a>), up 17.9%, in the growing group of April deals. Eight deals remain on the calendar for the rest of April.</p><p>
  <b>Chimerix Stock Rises After Pricing Upsized Deal</b>
</p><p>Chimerix, which is developing a potent antiviral drug for use in stem cell transplants, raised $102 million by offering 7.3 million shares at $14, within the range of $13 to $15. The Durham, N.C.-based company had originally planned to raise $85 million by offering 6.1 million shares before upsizing the Nasdaq-listed deal by 20%. Aisling Capital agreed to purchase $15 million of shares on</p><br/><a href='http://seekingalpha.com/article/1336511-chimerix-stock-soars-as-2-biotechs-debut-thursday?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/cmrx">CMRX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/omth">OMTH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/knop">KNOP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tmhc">TMHC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ibtx">IBTX</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>7 U.S. IPOs Planned For The Week Of April 8</title>
      <link>http://seekingalpha.com/article/1328731-7-u-s-ipos-planned-for-the-week-of-april-8?source=feed</link>
      <guid isPermaLink="false">1328731</guid>
      <content>
        <![CDATA[<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p><p><b>Chimerix</b> (<a href='http://seekingalpha.com/symbol/cmrx' title='Chimerix'>CMRX</a>), which is developing a potent antiviral drug for use in stem cell transplants, plans to raise $85 million by offering 6.1 million shares at a price range of $13.00 to $15.00. At the midpoint of the proposed range, Chimerix would command a market value of $325 million. Chimerix, which was founded in 2000, booked $34 million in sales over the last 12 months. The Durham, NC-based company plans to list on the NASDAQ under the symbol CMRX. Morgan Stanley and Cowen &amp; Company are the joint bookrunners on the deal.</p><p><b>EVERTEC</b> (<a href='http://seekingalpha.com/symbol/evtc' title='EVERTEC'>EVTC</a>), a leading full-service transaction processor in Puerto Rico and Latin America, plans to raise $400 million by offering 21.1 million shares at a price range of $18.00 to $20.00. At the midpoint of the proposed range, EVERTEC would command a market value of $1.6</p>]]>
      </content>
      <pubDate>Tue, 09 Apr 2013 02:35:09 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>The following <a href="http://www.renaissancecapital.com/ipohome/calendars/ondeck.aspx" rel="nofollow">IPOs are expected to price this week</a>:</p><p><b>Chimerix</b> (<a href='http://seekingalpha.com/symbol/cmrx' title='Chimerix'>CMRX</a>), which is developing a potent antiviral drug for use in stem cell transplants, plans to raise $85 million by offering 6.1 million shares at a price range of $13.00 to $15.00. At the midpoint of the proposed range, Chimerix would command a market value of $325 million. Chimerix, which was founded in 2000, booked $34 million in sales over the last 12 months. The Durham, NC-based company plans to list on the NASDAQ under the symbol CMRX. Morgan Stanley and Cowen &amp; Company are the joint bookrunners on the deal.</p><p><b>EVERTEC</b> (<a href='http://seekingalpha.com/symbol/evtc' title='EVERTEC'>EVTC</a>), a leading full-service transaction processor in Puerto Rico and Latin America, plans to raise $400 million by offering 21.1 million shares at a price range of $18.00 to $20.00. At the midpoint of the proposed range, EVERTEC would command a market value of $1.6</p><br/><a href='http://seekingalpha.com/article/1328731-7-u-s-ipos-planned-for-the-week-of-april-8?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/cmrx">CMRX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/evtc">EVTC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hart">HART</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/knop">KNOP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/omth">OMTH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/raly">RALY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tmhc">TMHC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ibtx">IBTX</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>U.S. IPO Recap: 9 Set Terms, 8 File As Market Springs To Life</title>
      <link>http://seekingalpha.com/article/1328721-u-s-ipo-recap-9-set-terms-8-file-as-market-springs-to-life?source=feed</link>
      <guid isPermaLink="false">1328721</guid>
      <content>
        <![CDATA[<p>The <a href="http://www.renaissancecapital.com/IPOHome/Press/MediaRoom.aspx?market=us" rel="nofollow">US IPO market</a> saw a jolt of activity last week, as nine companies set terms and eight submitted initial filings. The newly scheduled deals included two $500 million offerings, from top U.S. homebuilder Taylor Morrison (<a href='http://seekingalpha.com/symbol/tmhc' title='Taylor Morrison'>TMHC</a>) and leading satellite service provider Intelsat (<a href='http://seekingalpha.com/symbol/i' title='Intelsat SA'>I</a>), and the new filings were the most in more than a year. The spike in filing activity featured four very fast-growing technology companies, including three enterprise software vendors and a next-generation telecom equipment supplier. Independent Bank Group (<a href='http://seekingalpha.com/symbol/ibtx' title='Independent Bank Group'>IBTX</a>), a small Texas bank, was the week's lone <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOPricings.aspx" rel="nofollow">IPO pricing</a>. It priced at the high end of the range to raise $83 million, and traded up 10%.</p><p><b>Two large, private equity-backed deals from Taylor Morrison and Intelsat</b><br/> Taylor Morrison Home Corporation, an Oaktree (<a href='http://seekingalpha.com/symbol/oak' title='Oaktree Capital Group'>OAK</a>) and TPG-backed U.S. homebuilder, is the third IPO this year expecting strong growth because of the U.S. housing recovery. The previous</p>]]>
      </content>
      <pubDate>Tue, 09 Apr 2013 02:21:14 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>The <a href="http://www.renaissancecapital.com/IPOHome/Press/MediaRoom.aspx?market=us" rel="nofollow">US IPO market</a> saw a jolt of activity last week, as nine companies set terms and eight submitted initial filings. The newly scheduled deals included two $500 million offerings, from top U.S. homebuilder Taylor Morrison (<a href='http://seekingalpha.com/symbol/tmhc' title='Taylor Morrison'>TMHC</a>) and leading satellite service provider Intelsat (<a href='http://seekingalpha.com/symbol/i' title='Intelsat SA'>I</a>), and the new filings were the most in more than a year. The spike in filing activity featured four very fast-growing technology companies, including three enterprise software vendors and a next-generation telecom equipment supplier. Independent Bank Group (<a href='http://seekingalpha.com/symbol/ibtx' title='Independent Bank Group'>IBTX</a>), a small Texas bank, was the week's lone <a href="http://www.renaissancecapital.com/IPOHome/Press/IPOPricings.aspx" rel="nofollow">IPO pricing</a>. It priced at the high end of the range to raise $83 million, and traded up 10%.</p><p><b>Two large, private equity-backed deals from Taylor Morrison and Intelsat</b><br/> Taylor Morrison Home Corporation, an Oaktree (<a href='http://seekingalpha.com/symbol/oak' title='Oaktree Capital Group'>OAK</a>) and TPG-backed U.S. homebuilder, is the third IPO this year expecting strong growth because of the U.S. housing recovery. The previous</p><br/><a href='http://seekingalpha.com/article/1328721-u-s-ipo-recap-9-set-terms-8-file-as-market-springs-to-life?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/tmhc">TMHC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/i">I</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ibtx">IBTX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hasi">HASI</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/knop">KNOP</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/fwm">FWM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/raly">RALY</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/omth">OMTH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cmrx">CMRX</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>IPO Madness 2013: Round 2 Recap And Final 4 Preview</title>
      <link>http://seekingalpha.com/article/1328441-ipo-madness-2013-round-2-recap-and-final-4-preview?source=feed</link>
      <guid isPermaLink="false">1328441</guid>
      <content>
        <![CDATA[<p>With many of IPOs producing slam-dunk returns in 2013, Renaissance Capital would like to present the inaugural IPO Madness. To qualify, a company had to go public in 2013 and complete its listing by March 22. Whichever stock has the greater weekly return will survive to fight in another round until there is only one IPO left standing. We will publish recaps and previews of the matchups each week, so make sure to check out how your favorite IPOs do throughout the tournament. Check out the Round Two recaps and the Final Four match-ups below.</p>  <ul>
  <li>View bracket, first-round match-up previews, and team capsules <a href="http://www.renaissancecapital.com/ipohome/news/Renaissance-Capital-presents-IPO-Madness-2013-14011.html" rel="nofollow">here</a>.</li>
  <li>View first-round match-up recaps and second-round previews <a href="http://www.renaissancecapital.com/ipohome/news/IPO-Madness-2013:-Round-One-Recap-and-the-week-ahead-14080.html" rel="nofollow">here</a>.</li>
</ul><p>
  <strong>NYSE Region<br/></strong>
</p> <p>Equities-focused investment manager Artisan Partners Asset Management (<a href='http://seekingalpha.com/symbol/apam' title='Artisan Partners Asset Management'>APAM</a>) advanced to the Final Four by defeating TRI Pointe Homes (<a href='http://seekingalpha.com/symbol/tph' title='TRI Pointe Homes'>TPH</a>) in a tight match-up in a tough week for stock returns. Artisan Partners pulled off</p>        ]]>
      </content>
      <pubDate>Mon, 08 Apr 2013 19:22:35 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>With many of IPOs producing slam-dunk returns in 2013, Renaissance Capital would like to present the inaugural IPO Madness. To qualify, a company had to go public in 2013 and complete its listing by March 22. Whichever stock has the greater weekly return will survive to fight in another round until there is only one IPO left standing. We will publish recaps and previews of the matchups each week, so make sure to check out how your favorite IPOs do throughout the tournament. Check out the Round Two recaps and the Final Four match-ups below.</p>  <ul>
  <li>View bracket, first-round match-up previews, and team capsules <a href="http://www.renaissancecapital.com/ipohome/news/Renaissance-Capital-presents-IPO-Madness-2013-14011.html" rel="nofollow">here</a>.</li>
  <li>View first-round match-up recaps and second-round previews <a href="http://www.renaissancecapital.com/ipohome/news/IPO-Madness-2013:-Round-One-Recap-and-the-week-ahead-14080.html" rel="nofollow">here</a>.</li>
</ul><p>
  <strong>NYSE Region<br/></strong>
</p> <p>Equities-focused investment manager Artisan Partners Asset Management (<a href='http://seekingalpha.com/symbol/apam' title='Artisan Partners Asset Management'>APAM</a>) advanced to the Final Four by defeating TRI Pointe Homes (<a href='http://seekingalpha.com/symbol/tph' title='TRI Pointe Homes'>TPH</a>) in a tight match-up in a tough week for stock returns. Artisan Partners pulled off</p>        <br/><a href='http://seekingalpha.com/article/1328441-ipo-madness-2013-round-2-recap-and-final-4-preview?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/apam">APAM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/tph">TPH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wstc">WSTC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bcc">BCC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/lpdx">LPDX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/xone">XONE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/modn">MODN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/xoom">XOOM</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
    <item>
      <title>IPO Madness 2013: Round One Recap And The Week Ahead</title>
      <link>http://seekingalpha.com/article/1314561-ipo-madness-2013-round-one-recap-and-the-week-ahead?source=feed</link>
      <guid isPermaLink="false">1314561</guid>
      <content>
        <![CDATA[<p>
  <font>With many of the IPOs producing slam-dunk  returns in 2013, Renaissance Capital would like to present the  inaugural IPO Madness. To qualify, a company had to go public in 2013  and complete its listing by March 22. Whichever stock has the greater  weekly return will survive to fight in another round until there is only  one IPO left standing. We will publish recaps and previews of the  matchups each week, so make sure to check on how your favorite IPOs do  throughout the tournament. Check out the round one recaps and the round  two matchups below.</font>
</p><p>
  <font> </font>
</p><p>
  <font> <a href="http://www.renaissancecapital.com/ipohome/news/Renaissance-Capital-presents-IPO-Madness-2013-14011.html" rel="nofollow">View bracket, first round matchup previews and team capsules.</a> </font>
</p><p>
  <font> </font>
  <span/>
  <font> </font>
</p> <div>
  <p>
    <font> </font>
  </p>
</div> <p>
  <font>
    <font color="#ff7f00">
      <b>NYSE Region</b>
    </font>
  </font>
</p><p>
  <font> </font>
</p><p>
  <font>Starwood-Backed homebuilder <b><font color="#ff7f00">TRI Pointe Homes (<a href='http://seekingalpha.com/symbol/tph' title='TRI Pointe Homes'>TPH</a>)</font> </b>and equities-focused investment manager <b><font color="#ff7f00">Artisan Partners Asset Management (<a href='http://seekingalpha.com/symbol/apam' title='Artisan Partners Asset Management'>APAM</a>)</font></b> advanced to the second round. With a 3.3% return, TRI Pointe Homes advanced after outperforming <b><font color="#ff7f00">Zoetis (<a href='http://seekingalpha.com/symbol/zts' title='Zoetis'>ZTS</a>)</font></b> after the Pfizer spinoff ended the week up just</font>
</p>   ]]>
      </content>
      <pubDate>Tue, 02 Apr 2013 11:11:57 -0400</pubDate>
      <author>Renaissance Capital IPO Research</author>
      <description>
        <![CDATA[<strong>By <a href='http://www.renaissancecapital.com/RenCap/Default.aspx'>Renaissance Capital IPO Research</a>: </strong>
<p>
  <font>With many of the IPOs producing slam-dunk  returns in 2013, Renaissance Capital would like to present the  inaugural IPO Madness. To qualify, a company had to go public in 2013  and complete its listing by March 22. Whichever stock has the greater  weekly return will survive to fight in another round until there is only  one IPO left standing. We will publish recaps and previews of the  matchups each week, so make sure to check on how your favorite IPOs do  throughout the tournament. Check out the round one recaps and the round  two matchups below.</font>
</p><p>
  <font> </font>
</p><p>
  <font> <a href="http://www.renaissancecapital.com/ipohome/news/Renaissance-Capital-presents-IPO-Madness-2013-14011.html" rel="nofollow">View bracket, first round matchup previews and team capsules.</a> </font>
</p><p>
  <font> </font>
  <span/>
  <font> </font>
</p> <div>
  <p>
    <font> </font>
  </p>
</div> <p>
  <font>
    <font color="#ff7f00">
      <b>NYSE Region</b>
    </font>
  </font>
</p><p>
  <font> </font>
</p><p>
  <font>Starwood-Backed homebuilder <b><font color="#ff7f00">TRI Pointe Homes (<a href='http://seekingalpha.com/symbol/tph' title='TRI Pointe Homes'>TPH</a>)</font> </b>and equities-focused investment manager <b><font color="#ff7f00">Artisan Partners Asset Management (<a href='http://seekingalpha.com/symbol/apam' title='Artisan Partners Asset Management'>APAM</a>)</font></b> advanced to the second round. With a 3.3% return, TRI Pointe Homes advanced after outperforming <b><font color="#ff7f00">Zoetis (<a href='http://seekingalpha.com/symbol/zts' title='Zoetis'>ZTS</a>)</font></b> after the Pfizer spinoff ended the week up just</font>
</p>   <br/><a href='http://seekingalpha.com/article/1314561-ipo-madness-2013-round-one-recap-and-the-week-ahead?source=feed'>Complete Story &raquo;</a>]]>
      </description>
      <category type="symbol" link="http://seekingalpha.com/symbol/tph">TPH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/apam">APAM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/zts">ZTS</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cvrr">CVRR</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/wstc">WSTC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bcc">BCC</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/nclh">NCLH</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/bfam">BFAM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/lpdx">LPDX</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/xone">XONE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/cone">CONE</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/hiiq">HIIQ</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/modn">MODN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/xoom">XOOM</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/mrin">MRIN</category>
      <category type="symbol" link="http://seekingalpha.com/symbol/ssni">SSNI</category>
      <category type="author" link="http://seekingalpha.com/author/renaissance-capital-ipo-research">Renaissance Capital IPO Research</category>
    </item>
  </channel>
</rss>
